In the screening process of the dissolution method, the eftinib mesylate tablets showed faster dissolution under most conditions based on design considerations, this characteristic is determined by the prescription and key material properties (drug particle size) Cause: The drug substance is very small in particle size, D90 20 μm; the amount of disintegrant in the preparation is relatively high, this amount is usually 4% in tablets, and 6% in this product.
正在翻译中..